Evaluation of Clinical Prognostic Factors of Diffuse Large B-Cell Lymphoma (DLBCL) as Regards Treatment Outcome with CHOP Regimen-Retrospective Analysis (1998 -2006)

Marwa Nagi Mehesen;

Abstract


The aim of this retrospective study is to determine the efficacy, outcome and feasibility of standard CHOP regimen as a first line treatment to DLBCL using clinical risk stratification models such as International prognostic index (IPI) , patients profile


Other data

Title Evaluation of Clinical Prognostic Factors of Diffuse Large B-Cell Lymphoma (DLBCL) as Regards Treatment Outcome with CHOP Regimen-Retrospective Analysis (1998 -2006)
Authors Marwa Nagi Mehesen
Keywords Evaluation of Clinical Prognostic Factors of Diffuse Large B-Cell Lymphoma (DLBCL) as Regards Treatment Outcome with CHOP Regimen-Retrospective Analysis (1998 -2006)
Issue Date 2006
Description 
The aim of this retrospective study is to determine the efficacy, outcome and feasibility of standard CHOP regimen as a first line treatment to DLBCL using clinical risk stratification models such as International prognostic index (IPI) , patients profile

Attached Files

File SizeFormat
16945Dr. Marwa Nagi Mehesen.pdf113.32 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 4 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.